Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RBM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GNAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MUC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR157 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR24-2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LINC01138 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNPEP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STRIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSNK1D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JTB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPS8L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CIRBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MPC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMIGO3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM62 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CUTA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHKB-CPT1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LENG8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM147-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on